Huakang Biomed (08622): Shi Meiling resigns as independent non-executive director.

28/02/2025

GMT Eight

HUAKANG BIOMED (08622) announced that Shi Meiling has resigned as an independent non-executive director of the company, effective from February 28, 2025, in order to devote more time to her personal business and other matters.

OCUMENSION-B (01477) spent HKD 646,000 on February 28 to repurchase 144,000 shares.

CROWNICORP (00727) plans to conduct a stock merger.

Contact: contact@gmteight.com

Huakang Biomed (08622): Shi Meiling resigns as independent non-executive director.

RECOMMEND

The Japanese House of Representatives passed the new fiscal year budget, injecting a "shot in the arm" to secure power for Shigeru Ishiba in the election.

JP Morgan Analyzes Taiwan Semiconductor Manufacturing Co., Ltd. Sponsored ADR (TSM.US) CoWoS "Order Cut Doubts": Strong Demand Continues, Tightening Capacity Expected by 2025.

Subsidiary of Shanghai Fosun Pharmaceutical (600196.SH) obtains approval for clinical trial of 24-valent pneumonia vaccine.